Literature DB >> 33691695

Three case reports of patients indicating the diversity of molecular and clinical features of 16p11.2 microdeletion anomaly.

Monika Szelest1, Martyna Stefaniak1, Gabriela Ręka1, Ilona Jaszczuk2, Monika Lejman3.   

Abstract

BACKGROUND: 16p11.2 microdeletion is a known chromosomal anomaly associated mainly with neurocognitive developmental delay, predisposition to obesity, and variable dysmorphism. Although this deletion is relatively rare among the general population, it is one of the serious known genetic aetiologies of obesity and autism spectrum disorder. CASE
PRESENTATION: This study presents three cases of deletions within the 16p11.2 region. Every child had mild variable craniofacial abnormalities, hand or foot anomalies and developmental and language delays. The first proband had obesity, epilepsy, moderate intellectual disability, aphasia, motor delay, hyperinsulinism, and café au lait spots. The second proband suffered from cardiac, pulmonary, and haematological problems. The third proband had motor and language delays, bronchial asthma, and umbilical hernia. Although each patient presented some features of the syndrome, the children differed in terms of their clinical pictures. Genetic diagnosis of 16p11.2 microdeletion syndrome was made in children at different ages based on multiplex ligation probe-dependent amplification analysis and/or microarray methods.
CONCLUSIONS: Our reports allow us to analyse and better understand the biology of 16p11.2 microdeletion throughout development. However, the variability of presented cases supports the alternate conclusion to this presented in available literature regarding 16p11.2 deletion, as we observed no direct cause-and-effect genotype/phenotype relationships. The reported cases indicate the key role of the interdisciplinary approach in 16p11.2 deletion diagnostics. The care of patients with this anomaly is based on regular health assessment and adjustment of nervous system development therapy.

Entities:  

Keywords:  16p11.2; Autism spectrum disorder; MLPA; Microarray; Microdeletion anomaly

Year:  2021        PMID: 33691695      PMCID: PMC7945342          DOI: 10.1186/s12920-021-00929-8

Source DB:  PubMed          Journal:  BMC Med Genomics        ISSN: 1755-8794            Impact factor:   3.063


  34 in total

1.  Transcriptional consequences of 16p11.2 deletion and duplication in mouse cortex and multiplex autism families.

Authors:  Ian Blumenthal; Ashok Ragavendran; Serkan Erdin; Lambertus Klei; Aarathi Sugathan; Jolene R Guide; Poornima Manavalan; Julian Q Zhou; Vanessa C Wheeler; Joshua Z Levin; Carl Ernst; Kathryn Roeder; Bernie Devlin; James F Gusella; Michael E Talkowski
Journal:  Am J Hum Genet       Date:  2014-06-05       Impact factor: 11.025

2.  The 16p11.2 deletion mouse model of autism exhibits altered cortical progenitor proliferation and brain cytoarchitecture linked to the ERK MAPK pathway.

Authors:  Joanna Pucilowska; Joseph Vithayathil; Emmanuel J Tavares; Caitlin Kelly; J Colleen Karlo; Gary E Landreth
Journal:  J Neurosci       Date:  2015-02-18       Impact factor: 6.167

3.  An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities.

Authors:  Erin B Kaminsky; Vineith Kaul; Justin Paschall; Deanna M Church; Brian Bunke; Dawn Kunig; Daniel Moreno-De-Luca; Andres Moreno-De-Luca; Jennifer G Mulle; Stephen T Warren; Gabriele Richard; John G Compton; Amy E Fuller; Troy J Gliem; Shuwen Huang; Morag N Collinson; Sarah J Beal; Todd Ackley; Diane L Pickering; Denae M Golden; Emily Aston; Heidi Whitby; Shashirekha Shetty; Michael R Rossi; M Katharine Rudd; Sarah T South; Arthur R Brothman; Warren G Sanger; Ramaswamy K Iyer; John A Crolla; Erik C Thorland; Swaroop Aradhya; David H Ledbetter; Christa L Martin
Journal:  Genet Med       Date:  2011-09       Impact factor: 8.822

4.  Abnormal Speech Motor Control in Individuals with 16p11.2 Deletions.

Authors:  Carly Demopoulos; Hardik Kothare; Danielle Mizuiri; Jennifer Henderson-Sabes; Brieana Fregeau; Jennifer Tjernagel; John F Houde; Elliott H Sherr; Srikantan S Nagarajan
Journal:  Sci Rep       Date:  2018-01-19       Impact factor: 4.996

5.  An interaction-based model for neuropsychiatric features of copy-number variants.

Authors:  Matthew Jensen; Santhosh Girirajan
Journal:  PLoS Genet       Date:  2019-01-17       Impact factor: 5.917

6.  Rare variants in the genetic background modulate cognitive and developmental phenotypes in individuals carrying disease-associated variants.

Authors:  Lucilla Pizzo; Matthew Jensen; Andrew Polyak; Jill A Rosenfeld; Katrin Mannik; Arjun Krishnan; Elizabeth McCready; Olivier Pichon; Cedric Le Caignec; Anke Van Dijck; Kate Pope; Els Voorhoeve; Jieun Yoon; Paweł Stankiewicz; Sau Wai Cheung; Damian Pazuchanics; Emily Huber; Vijay Kumar; Rachel L Kember; Francesca Mari; Aurora Curró; Lucia Castiglia; Ornella Galesi; Emanuela Avola; Teresa Mattina; Marco Fichera; Luana Mandarà; Marie Vincent; Mathilde Nizon; Sandra Mercier; Claire Bénéteau; Sophie Blesson; Dominique Martin-Coignard; Anne-Laure Mosca-Boidron; Jean-Hubert Caberg; Maja Bucan; Susan Zeesman; Małgorzata J M Nowaczyk; Mathilde Lefebvre; Laurence Faivre; Patrick Callier; Cindy Skinner; Boris Keren; Charles Perrine; Paolo Prontera; Nathalie Marle; Alessandra Renieri; Alexandre Reymond; R Frank Kooy; Bertrand Isidor; Charles Schwartz; Corrado Romano; Erik Sistermans; David J Amor; Joris Andrieux; Santhosh Girirajan
Journal:  Genet Med       Date:  2018-09-07       Impact factor: 8.822

7.  Medical consequences of pathogenic CNVs in adults: analysis of the UK Biobank.

Authors:  Karen Crawford; Matthew Bracher-Smith; David Owen; Kimberley M Kendall; Elliott Rees; Antonio F Pardiñas; Mark Einon; Valentina Escott-Price; James T R Walters; Michael C O'Donovan; Michael J Owen; George Kirov
Journal:  J Med Genet       Date:  2018-10-20       Impact factor: 6.318

8.  Zebrafish homologs of genes within 16p11.2, a genomic region associated with brain disorders, are active during brain development, and include two deletion dosage sensor genes.

Authors:  Alicia Blaker-Lee; Sunny Gupta; Jasmine M McCammon; Gianluca De Rienzo; Hazel Sive
Journal:  Dis Model Mech       Date:  2012-05-01       Impact factor: 5.758

9.  R-Baclofen Reverses Cognitive Deficits and Improves Social Interactions in Two Lines of 16p11.2 Deletion Mice.

Authors:  Laura J Stoppel; Tatiana M Kazdoba; Melanie D Schaffler; Anthony R Preza; Arnold Heynen; Jacqueline N Crawley; Mark F Bear
Journal:  Neuropsychopharmacology       Date:  2017-10-06       Impact factor: 7.853

10.  Understanding the clinical manifestations of 16p11.2 deletion syndrome: a series of developmental case reports in children.

Authors:  Rana Fetit; David J Price; Stephen M Lawrie; Mandy Johnstone
Journal:  Psychiatr Genet       Date:  2020-10       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.